| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CM-101 (ChemomAb) | CM-101 | Phase 2 Clinical | Chemomab Therapeutics Ltd | Metabolic Dysfunction-Associated Steatotic Liver Disease; Scleroderma, Systemic; Cholangitis, Sclerosing | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



